GLYBURIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for glyburide and what is the scope of freedom to operate?
Glyburide
is the generic ingredient in seven branded drugs marketed by Sanofi Aventis Us, Actavis Elizabeth, Aurobindo Pharma, Cadila Pharms Ltd, Chartwell Rx, Epic Pharma Llc, Heritage, Impax Labs Inc, Orient Pharma Co Ltd, Teva, Zydus Pharms, Hikma, Natco Pharma, Strides Pharma, Pfizer, and Bristol Myers Squibb, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.There are twenty drug master file entries for glyburide. Nineteen suppliers are listed for this compound.
Summary for GLYBURIDE
US Patents: | 0 |
Tradenames: | 7 |
Applicants: | 16 |
NDAs: | 27 |
Drug Master File Entries: | 20 |
Finished Product Suppliers / Packagers: | 19 |
Raw Ingredient (Bulk) Api Vendors: | 152 |
Clinical Trials: | 74 |
Patent Applications: | 7,057 |
Drug Prices: | Drug price trends for GLYBURIDE |
Drug Sales Revenues: | Drug sales revenues for GLYBURIDE |
What excipients (inactive ingredients) are in GLYBURIDE? | GLYBURIDE excipients list |
DailyMed Link: | GLYBURIDE at DailyMed |
Recent Clinical Trials for GLYBURIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Maryland, Baltimore | Phase 2 |
University of Kentucky | Phase 1 |
Medical College of Wisconsin | Phase 4 |
Pharmacology for GLYBURIDE
Drug Class | Sulfonylurea |
Medical Subject Heading (MeSH) Categories for GLYBURIDE
US Patents and Regulatory Information for GLYBURIDE
Expired US Patents for GLYBURIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-002 | May 1, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLYNASE | glyburide | TABLET;ORAL | 020051-002 | Mar 4, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLYNASE | glyburide | TABLET;ORAL | 020051-001 | Mar 4, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLYNASE | glyburide | TABLET;ORAL | 020051-001 | Mar 4, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-001 | May 1, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | DIABETA | glyburide | TABLET;ORAL | 017532-002 | May 1, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | GLYNASE | glyburide | TABLET;ORAL | 020051-002 | Mar 4, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.